A reader asked me to take a look at their results from these three. This is not a fun exercise because the data is not machine processable, time consuming and thus prone to more significant errors. The best way to proceed is to use one of these providers.
- Biome Sight with “MICRO” as discount code,
- Thryve Inside
- Nirvana Biome (which also reports on virus and fungi)
GI Map Results
The following abnormalities were reported. We cannot get the percentile ranking from MicrobiomePrescription.com because they give counts without declaring what 100% is, it appears to be over 3.3E12 i.e. 3,300,000,000,000, since that is the upper limit for one of the phyla. I attempted on computation below with nonsense results.
- Clostridia (class) – 200% above their upper limit
- Enterobacter spp. – 60% above their upper limit
- Akkermansia muciniphila – 3700% above their upper limit
- Firmicutes – 29% above their upper limit
- Bacteroidetes – 29% below their lower limit
- Bacillus spp. – 433% above their upper limit
- Enterococcus faecalis – 800% above their upper limit
- Streptococcus spp. 550% above their upper limit
So, their numbers are useless. We can do manual entry of highs/lows on this page and get very coarse suggestions.
I did a tally of their evalutaions:
- Not Optimal: xxx or 16%
- Average: xxxxxxxxxxxxxx or 74%
- Good: xx or 10%
They list the bacteria found but with no percentages or other quantities…
IMHO. Viome is not worth anything, at least nothing that can used with microbiome prescription data sources.
This person did a biomesight.com test which was one-button-pushed transferred over (thank you Rose again for making life easier for many people).
Starting with Enzyme production,
We get core probiotics suggestions with lactobacillus paracasei again being dominant (as it was in the last posts).
For EndProduct Outliers, we have only one item being low, Urolithins. Nothing under KEGG Module.
Next we look at Core Supplements suggested (these are items that your bacteria may be producing less of due to dysfunction)
Looking at Hawrelak recommended levels we see that Akkermansia is LOW, but GI-MAP reported a massive overgrowth!
The next item in my current pro-forma analysis is looking at quick suggestions and the diagnosis specific suggestion. This person’s diagnosis is Rosacea Sub-Type 2 (Inflammatory / Papulopustular/ Acne rosacea) which I do not have in my database. Going over to pubmed to see if there is any appropriate studies, I only found skin studies.
- The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up.
- The association between cigarettes smoke, small intestine bacterial overgrowth and rosacea
- Topical probiotics: the unknowns behind their rising popularity.
- An altered fecal microbial profiling in rosacea patients compared to matched controls 
- Bacterial and fungal microbiome characterization in patients with rosacea and healthy controls 
- Characterization of the facial microbiome in twins discordant for rosacea.
- The fungal flora of the digestive tract in patients with acne rosacea
- Microbiota in Rosacea
From those and similar, I create a database entry.
Remember, this is done without any reference to conditions or symptoms.
With the new medical condition and studies added, I no results with the tightest selection and ended up expanding the selection as shown below.
We have two probiotics that should definitely be considered, lactobacillus paracasei and B. longum. Holigos was an interesting item to appear, and I have heard very favorable reports on it. I would suggest getting Vitamin D level, and unless you are in the top 20% of the normal range, supplement appropriately. For other supplements: selenium, magnesium, GABA.
These are suggestions to discuss with your knowledgeable medical professional before starting. Frequently items require to be balanced with other supplement which such a resource may help you with.
I also used the GI Maps results alone with the page cited above and got the following list, with Holigos being at the top. We also see lactobacillus paracasei appearing close to the top of the list.